Freedland Cory S. 4
4 · Neurogene Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Freedland Cory S.
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-12+12,050→ 12,050 totalExercise: $20.40Exp: 2035-06-12→ Common Stock (12,050 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the total shares monthly beginning July 12, 2025 until the option is fully vested on June 12, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.